Connect with us

breaking news

House revives talks to decriminalize cannabis use in the Philippines

Published

on


Former House Speaker Pantaleon Alvarez, who used profanity to describe the classification of cannabis as a dangerous drug, argues that its legalization would generate revenues for the government

A House panel for the first time in the 19th Congress under the Marcos administration took up a bill seeking to decriminalize the production, sale, and use of cannabis in the Philippines.

The lower chamber’s dangerous drugs committee chaired by Robert Ace Barbers of Surigao del Norte’s 2nd District moved to form a technical working group (TWG) with the health committee to flesh out the bill filed by former House Speaker and current Davao del Norte 1st District Representative Pantaleon Alvarez.

In his speech, Alvarez used colorful language to describe the current state of cannabis in the country.

“The classification of cannabis and its derivatives, as a dangerous drug, is bullsh*t. It makes no sense at all. And we must correct this absurdity,” he said on Tuesday, February 21.

“If the government allows harmful products like alcoholic beverages, cancer-causing cigarettes, and diabetes-bringing sugary drinks, why can’t we decriminalize the production and sale of a substance that is less harmful, has many benefits, and can be a source of government revenue?” Alvarez said.

The former House leader also argued that legalizing marijuana in the Philippines would generate wealth that the government can use for its programs and projects.

“We can decriminalize cannabis and its derivatives, and we can collect billions worth of taxes from its production and sale. We can use the added revenues to build more roads and bridges, more classrooms and hospitals, and more public service in pursuit of the common good. We can also use the extra taxes collected to help our country pay for our deep debt brought on by the economic crisis during the pandemic,” Alvarez said.

What the bill says

Republic Act No. 9165, also known as the amended Comprehensive Dangerous Drugs Act, lists cannabis as a dangerous drug and substance.

Individuals convicted of cultivating marijuana, and possessing 10 grams of marijuana resin or marijuana resin oil, as well as 500 grams or more of marijuana, face a fine of up to P10 million and life imprisonment.

Alvarez’s proposal, House Bill No. 6783, seeks to exclude cannabis, cannabis resin and extracts, and tinctures of cannabis from the list.

Batanes Representative Ciriaco Gato expressed concern that the delisting of cannabis would pave the way for the recreational use of marijuana.

“I am thinking that while alcohol and tobacco are really bad, marijuana is also bad. As to which is more harmful, I think it depends on the amount,” Gato said, arguing that a variety of cannabis has negative effects. “Marijuana just like alcohol has some effects from a medical and social standpoint.”

Outlook

The proposal is in its early stages, and it is not among the priority bills of the Marcos administration.

The dangerous drugs committee also seeks to conduct further review on the subject.

“I would like to listen first to the opinions of all the members, and opinions of the experts,” Barbers told Rappler when asked whether he would back the measure and eventually defend it at the House plenary.

“A lot of discussions will have to be made because if the proponent’s intention is to delist it, there must be some basis as to why he wants to delist it,” he said. “Before we pursue the idea of making it available for sale, it has to be delisted [from the list of dangerous drugs].”

Aside from the bill filed by Alvarez, there are also multiple bills referred to the health committee seeking to legalize medical marijuana.

That panel has yet to take up such measures, chairman Gato told Rappler, but he said he is in favor of medical, regulated marijuana.

The House, led by then-Speaker Gloria Macapagal Arroyo in the 17th Congress, already approved a bill seeking to legalize medical marijuana, but the proposal languished in the Senate. The lower chamber in the 18th Congress, however, failed to move past the TWG level. – Rappler.com

Source:

https://www.rappler.com/nation/house-panel-bill-revives-talks-decriminalize-marijuana-use-philippines/



Source link

Continue Reading

breaking news

Massachusetts: Office of the Inspector General Publishes Press Release Re Appointing A Receiver To Manage State’s Cannabis Commission

Published

on

By


Independent journalist Grant Smith Ellis  writes today to linked in

Press release from Massachusetts Inspector General confirms that a decision in June of 2024, by three CCC Commissioners, to strip the powers of acting agency Executive Director Debbie Hilton-Creek led to today’s emergency hearing request on Beacon Hill.

 



Source link

Continue Reading

breaking news

Movie Time In Oregon. Special Screening of Frenchy Dreams of Hashish

Published

on

By


CHEECHABLE & OG EMPIRE PRESENT:

A SPECIAL 7/10 with FRENCHY CANNOLI! We are pleased to announce a special screening and Oregon premier of the movie Frenchy Dreams of Hashish, a documentary by Jake Remington. Frenchy Dreams of Hashish showcases master hashishin Frenchy Cannoli’s lifelong pursuit of perfect hashish and highlights the ethos of sustainable, sun-grown cannabis. Join us as we celebrate the art of making hash and honor the late master, Frenchy Cannoli. Get your tickets here!

 



Source link

Continue Reading

breaking news

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

Published

on

By


It’ll take a while but the business plan to get Curaleaf products available via the NHS starts here…and the front man is  now former Conservative MP George Freeman

See the press release dated 28 May (scroll down)  about his involvement and and what a surprise

30 May 2024

George Freeman is no longer a Member, but was most recently the Conservative MP for Mid Norfolk, and left the Commons on 30 May 2024.

https://members.parliament.uk/member/4020/career

 

 

 

Positioned at the heart of the life sciences sector, the Cannabinoid Research & Development Group UK is a new research strategy group led by academics, researchers, clinicians, patients and industry.

The group will propel scientific research and development of pharmaceutical cannabinoid-related products in the UK.

Our ambition is to develop and implement a comprehensive strategy to transform the UK into the global leader in cannabinoid research and medicine development.

We will build a robust ecosystem by integrating universities, research institutions, investors, businesses, and the NHS – driving innovation and development, nurturing top talent and fostering advances in healthcare.

 

 



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media